Article Information
History
- December 9, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Mohammed Al-Jumaan1,*,
- Hoyin Chu2,3,*,
- Abdullah Al-Sulaiman1,
- Sabrina Y. Camp2,3,
- Seunghun Han2,4,
- Riaz Gillani3,5,6,7,
- Yousef Al Marzooq1,
- Fatmah Almulhim1,
- Chittibabu Vatte1,
- Areej Al Nemer1,
- Afnan Almuhanna1,
- Eliezer M Van Allen2,3,8,
- Amein Al-Ali1,^,† and
- Saud H AlDubayan2,3,9,10,^,†
- 1College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Saudi Arabia
- 2Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
- 3Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA, USA
- 4Harvard Medical School, Boston, MA, USA
- 5Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
- 6Department of Pediatrics, Harvard Medical School, Boston, MA, USA
- 7Boston Children’s Hospital, Boston, MA, USA
- 8Center for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA 02115, USA
- 9Division of Genetics, Brigham and Women’s Hospital, Boston, MA, USA
- 10College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
- ↵†Corresponding Author:
Saud H. AlDubayan, MD (SAUD_ALDUBAYAN{at}DFCI.HARVARD.EDU), Dana-Farber Cancer Institute, 41 Avenue Louis Pasteur, Suite 303-01, Boston, MA, 02115, Tel. 617-515-5776, Amein Al-Ali, Chair Professor, College of Medicine, Department of Biochemistry, Imam Abdulrahman bin Faisal University (aalali{at}iau.edu.sa)